Click here for prescribing informationNEXPLANON® (etonogestrel 68 mg implant) is indicated for contraception.
Safety and efficacy have been established in women between 18 and 40 years of age.1



The home of NEXPLANON®
(etonogestrel 68 mg implant)

NEXPLANON® is a sub dermal contraceptive implant that lasts for up to 3 years and is over 99% effective1

During the clinical studies no pregnancies were observed during 35,057 cycles of exposure; the Pearl Index observed is 0.00 (95 % confidence limits: 0.00-0.14). However, it must be realised that in practice no method can be considered 100 % effective.

Nexplace offers access to training and development resources, patient support materials and more. Join today!


Need more information?

Contact your local representative

Please click the button below, send us an email and we will be in contact as soon as possible.

Start your Nexplace journey

Register today to join the Nexplace community and get access to exclusive NEXPLANON® training and resources.


  1. NEXPLANON® Summary of Product Characteristics
Adverse events should be reported. Reporting forms and information can be found at
or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Organon Pharma (UK) Limited. (Tel: 02081 593593). By clicking the above link you will leave the Organon website and be taken to the MHRA website.

Supporting documentation

Prescribing Information Summary of Product Characteristics | Patient Information Leaflet

By clicking the above links you will leave the Organon website and be taken to external websites.

GB-XPL-115497 | Date of Preparation October 2023